MICHAEL S WYZGA
CIK 1201256 · Chief Executive Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$31.2K
Companies
11
Total Filings
66
Lifetime Open-Market Net
-$6.56M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVRD | Director | — | $2.64 | — | $0 | 2 | 2026-06-11 |
| MREO | Director | 25,050 | $0.30 | $7.6K | $0 | 4 | 2026-02-27 |
| XFOR | Director | 5,555 | $4.00 | $22.2K | $29.9K | 10 | 2026-01-05 |
| IVVD | Director | — | $0.77 | — | $0 | 1 | 2023-05-25 |
| LOGC | Director | 0 | $7.06 | $0 | $0 | 7 | 2022-11-17 |
| Invivyd, Inc. (ADGI) Delisted | Director | — | $4.64 | — | $0 | 2 | 2022-06-24 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 2,558 | $104.91 | $268.4K | -$3.68M | 12 | 2021-03-02 |
| AKBA | Director | 1,500 | $0.92 | $1.4K | $25.5K | 5 | 2018-06-15 |
| IDENIX PHARMACEUTICALS INC (IDIX) Delisted | Director | — | — | — | $0 | 4 | 2014-08-05 |
| GENZYME CORP (GENZ) Delisted | Executive VP and CFO | 0 | — | — | -$2.94M | 8 | 2011-04-06 |
| Altus Pharmaceuticals Inc. (ALTU) Delisted | Director | — | $10.12 | — | $0 | 4 | 2009-07-02 |
Recent Filings · Page 3 of 7
66 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-02 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | −8,913 | -$2.20M | EDGAR |
| 2021-01-04 | LOGC | Exer (M) | +3,141 | $0 | EDGAR |
| 2020-07-24 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +2,558 | $0 | EDGAR |
| 2020-06-23 | LOGC | Grant (A) | — | $0 | EDGAR |
| 2020-06-11 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2019-12-20 | LOGC | Grant (A) | — | $0 | EDGAR |
| 2019-08-02 | EXACT SCIENCES CORP (EXAS) Delisted | Mixed | −2,500 | -$522.2K | EDGAR |
| 2019-07-26 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +2,801 | $0 | EDGAR |
| 2019-04-02 | XFOR | Grant (A) | — | $0 | EDGAR |
| 2019-03-14 | XFOR | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.